Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Islasertib by Thryv Therapeutics for Arrhythmias: Likelihood of Approval
Islasertib is under clinical development by Thryv Therapeutics and currently in Phase II for Arrhythmias. According to GlobalData, Phase II...